von Willebrand factor: a marker of endothelial dysfunction in vascular disorders?

GYH Lip, A Blann - Cardiovascular research, 1997 - academic.oup.com
The vascular endothelium is involved in the production of many important substances which
are involved in cardiovascular pathophysiology. One such substance which is synthesised …

Exercise and training effects on blood haemostasis in health and disease: an update

MS El-Sayed, Z El-Sayed Ali, S Ahmadizad - Sports medicine, 2004 - Springer
In recent years, the dysfunction of the haemostatic system in relation to the clinical
complications from arterioscleroses and cardiovascular diseases has become more …

High plasminogen activator inhibitor and tissue plasminogen activator levels in plasma precede a first acute myocardial infarction in both men and women: evidence …

AM Thögersen, JH Jansson, K Boman, TK Nilsson… - Circulation, 1998 - Am Heart Assoc
Background—In patients with established ischemic heart disease, prospective cohort
studies have indicated that plasminogen activator inhibitor (PAI-1), the inhibitor of the …

Genetics of atherosclerosis

AJ Lusis, R Mar, P Pajukanta - Annu. Rev. Genomics Hum …, 2004 - annualreviews.org
▪ Abstract Atherosclerosis, the primary cause of coronary artery disease (CAD) and stroke, is
a disorder with multiple genetic and environmental contributions. Genetic-epidemiologic …

Blood hemostasis in exercise and training.

MS El-Sayed, C Sale, PG Jones… - Medicine and science in …, 2000 - europepmc.org
Formation of the blood clot is a slow but normal physiological process occurring as a result
of the activation of blood coagulation pathways. Nature's guard against unwanted blood …

Effects of exercise on blood coagulation, fibrinolysis and platelet aggregation

MS El-Sayed - Sports medicine, 1996 - Springer
Disturbances of the haemostatic balance may result in thrombosis or bleeding tendency.
There have been abundant reports on the effects of exercise on blood haemostasis, but the …

Fibrates in 2003: therapeutic action in atherogenic dyslipidaemia and future perspectives

MJ Chapman - Atherosclerosis, 2003 - Elsevier
Objectives: To explore the therapeutic potential of fibrates to attenuate premature
atherosclerosis and cardiovascular disease in the atherogenic dyslipidemias typical of Type …

[PDF][PDF] Coronary atherogenic risk factors in women

V Stangl, G Baumann, K Stangl - European Heart Journal, 2002 - researchgate.net
Cardiovascular disease, primarily coronary heart disease (CHD), remains the most frequent
cause of death in Western industrialized nations: nearly one in every two deaths are …

Tissue plasminogen activator, plasminogen activator inhibitor-1, and tissue plasminogen activator/plasminogen activator inhibitor-1 complex as risk factors for the …

L Johansson, JH Jansson, K Boman, TK Nilsson… - Stroke, 2000 - Am Heart Assoc
Background and Purpose—Abnormalities in the fibrinolytic system have been associated
with an increased risk for stroke in a few studies. This study was designed to test whether …

Work stress and metabolic and hemostatic risk factors

TGM Vrijkotte, LJP Van Doornen… - Psychosomatic …, 1999 - journals.lww.com
Objective A high level of work stress has been associated with cardiovascular disease.
However, the pathophysiological mechanisms underlying this association remain unclear …